anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.09.15 | Roche buy | Kepler Cheuvreux | |
| 28.09.15 | Roche verkaufen | Goldman Sachs Group Inc. | |
| 25.09.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.09.15 | Roche buy | Deutsche Bank AG | |
| 23.09.15 | Novartis buy | Citigroup Corp. | |
| 16.09.15 | Novartis buy | HSBC | |
| 15.09.15 | Roche buy | Goldman Sachs Group Inc. | |
| 10.09.15 | Roche buy | Jefferies & Company Inc. | |
| 10.09.15 | Novartis buy | Jefferies & Company Inc. | |
| 03.09.15 | Novartis Halten | Independent Research GmbH | |
| 01.09.15 | Novartis buy | UBS AG | |
| 24.08.15 | Novartis buy | UBS AG | |
| 21.08.15 | Roche buy | UBS AG | |
| 13.08.15 | Roche buy | HSBC | |
| 07.08.15 | Novartis buy | Jefferies & Company Inc. | |
| 07.08.15 | Roche buy | Jefferies & Company Inc. | |
| 29.07.15 | Roche buy | UBS AG | |
| 29.07.15 | Roche overweight | JP Morgan Chase & Co. | |
| 28.07.15 | Roche overweight | Barclays Capital | |
| 27.07.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.07.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 27.07.15 | Novartis buy | UBS AG | |
| 24.07.15 | Roche overweight | Morgan Stanley | |
| 24.07.15 | Novartis buy | Kepler Cheuvreux | |
| 23.07.15 | Novartis Outperform | BNP PARIBAS | |
| 22.07.15 | Novartis Equal weight | Barclays Capital | |
| 22.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.07.15 | Novartis Equal-Weight | Morgan Stanley | |
| 21.07.15 | Novartis Hold | S&P Capital IQ | |
| 21.07.15 | Novartis Halten | Independent Research GmbH | |
| 14.07.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.07.15 | Roche buy | UBS AG | |
| 13.07.15 | Novartis buy | Citigroup Corp. | |
| 13.07.15 | Novartis buy | Jefferies & Company Inc. | |
| 13.07.15 | Roche buy | Jefferies & Company Inc. | |
| 10.07.15 | Novartis buy | UBS AG | |
| 09.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 08.07.15 | Roche overweight | JP Morgan Chase & Co. | |
| 07.07.15 | Novartis buy | UBS AG | |
| 06.07.15 | Novartis overweight | JP Morgan Chase & Co. |